← Back to Search

Harness Support During Walking for Cerebral Palsy

N/A
Recruiting
Led By Katherine Steele, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No surgery within the last 9 months
8-17 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one-time research visit (15 minutes)
Awards & highlights
No Placebo-Only Group

Summary

This trial will help to understand why people with cerebral palsy have such high energy costs when walking, in order to develop better treatments.

Who is the study for?
This trial is for children aged 8-17 with bilateral cerebral palsy, specifically those who can walk and have a certain level of motor function. They should not have had recent surgery or muscle spasm treatments and must be able to understand instructions.
What is being tested?
The study tests how different levels of harness support affect the energy used by children with CP while walking. It aims to understand why walking consumes more energy for them and will measure oxygen use during various walking tasks.
What are the potential side effects?
Since this trial involves non-invasive procedures like walking with harness support, there are minimal expected side effects, primarily related to physical exertion such as potential fatigue or discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I haven't had surgery in the last 9 months.
Select...
I am between 8 and 17 years old.
Select...
I have moderate motor function difficulties.
Select...
I have been diagnosed with cerebral palsy affecting both sides of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one-time research visit (15 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and one-time research visit (15 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Oxygen
Secondary study objectives
Lower Extremity
Passive joint range of motion
Selective motor control
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Typically Developing Children (Controls)Experimental Treatment1 Intervention
Children meeting inclusion/exclusion criteria without a diagnosis of cerebral palsy or other condition.
Group II: Children with Cerebral Palsy (Cases)Experimental Treatment1 Intervention
Children meeting inclusion/exclusion criteria with a diagnosis of cerebral palsy.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,817 Previous Clinical Trials
1,914,342 Total Patients Enrolled
10 Trials studying Cerebral Palsy
1,164 Patients Enrolled for Cerebral Palsy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,055 Previous Clinical Trials
2,731,854 Total Patients Enrolled
33 Trials studying Cerebral Palsy
8,872 Patients Enrolled for Cerebral Palsy
Gillette Children's Specialty HealthcareOTHER
30 Previous Clinical Trials
8,031 Total Patients Enrolled
13 Trials studying Cerebral Palsy
2,410 Patients Enrolled for Cerebral Palsy

Media Library

Varying levels of harness support during walking Clinical Trial Eligibility Overview. Trial Name: NCT04303078 — N/A
Cerebral Palsy Research Study Groups: Children with Cerebral Palsy (Cases), Typically Developing Children (Controls)
~7 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top